CoChat

A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk

Open access
Alden, C. L., Lynn, A., Bourdeau, A., Morton, D., Sistare, F. D., Kadambi, V. J., Silverman, L. · 2011 · Veterinary Pathology

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

The pharmaceutical industry and regulatory agency toxicology testing paradigms in the United States currently appear successful, in part because of the continuously increasing life expectancy and the declining age-adjusted cancer rates in the United States. Although drugs likely have a minimal impact on the population statistics for cancer rates, pharmaceutical pathologists and toxicologists must focus on the individual risk for pharmaceutical carcinogenesis. As our understanding of carcinogenesis increases exponentially, and after hundreds if not thousands of rodent cancer tests, significant improvement in the precision of human pharmaceutical carcinogenesis hazard identification should now be possible and would enable a reduction in the substantial false-negative and false positive-rates reported herein. The appropriate use of acute, subchronic, chronic, and special toxicology tests to identify the major associated cancer risk factors, specifically, hormonal modulation, immunosuppression, genetic toxicity, and chronic toxicity, can be recognized through this review of pharmaceutical carcinogens. Significant opportunities exist for improving the effectiveness and efficiency of the current cancer risk assessment paradigm.

Overview

Integrity signals

Registry

Crossref · 10.1177/0300985811400445

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Arias E: United States Life Tables, 2006. In: National Vital Statistics Reports, Division of Vital Statistics, vol. 8, doc no. 21; 2010.
  2. Rubin E, Farber JL: The liver and biliary tract. In: Pathology. JB Lippincott Co., Philadelphia, 1988.

Cited by

See all 69

Metadata

Authors
Alden, C. L., Lynn, A., Bourdeau, A., Morton, D., Sistare, F. D., Kadambi, V. J., & Silverman, L.
Affiliations
  • Takeda Oncology (United States) (US)
  • Pfizer (United States) (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author
Lynn, A.
Venue
Veterinary Pathology
Published
2011-03-07
Volume
48
Issue
3
Pages
772-784
ISSN
  • 0300-9858 (ISSN-L)
  • 1544-2217
OpenAlex
W2132201383
Cited by
69
References
37
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 8 · 2014: 7 · 2013: 8 · 2012: 4
FWCI
0.49
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Veterinary Pathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
rodent carcinogenicity testing, hazard identification, hormonal modulation, immunosuppression, genotoxicity, chronic toxicity, cancer risk assessment, drug safety testing
MeSH terms
Animals, Biological Assay, Humans, Risk Factors, Rodentia, Carcinogenicity Tests, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.